{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T19:57:51Z","timestamp":1787169471599,"version":"build-2736575974"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,1,19]]},"DOI":"10.7759\/cureus.21409","type":"journal-article","created":{"date-parts":[[2022,1,19]],"date-time":"2022-01-19T07:27:21Z","timestamp":1642577241000},"source":"Crossref","is-referenced-by-count":2,"title":["Preoperative Predictors of Optimal Tumor Resectability in Patients With Epithelial Ovarian Cancer"],"prefix":"10.7759","author":[{"given":"Kehinde S","family":"Okunade","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adaiah P","family":"Soibi-Harry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benedetto","family":"Osunwusi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ephraim","family":"Ohazurike","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah O","family":"John-olabode","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adeyemi","family":"Okunowo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Garba","family":"Rimi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Omolola","family":"Salako","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muisi","family":"Adenekan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rose","family":"Anorlu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","article-title":"Histopathological patterns of ovarian tumours seen in Lagos University Teaching Hospital: a ten year retrospective study","volume":"21","author":"Onyiaorah IV","year":"2011","unstructured":"Onyiaorah IV, Anunobi CC, Banjo AA, Fatima AA, Nwankwo KC. Histopathological patterns of ovarian tumours seen in Lagos University Teaching Hospital: a ten year retrospective study. Nig Q J Hosp Med. 2011, 21:114-8.","journal-title":"Nig Q J Hosp Med"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.4103\/1118-4647.187901","article-title":"A five year review of ovarian cancer at a tertiary institution in Lagos, South-West, Nigeria","volume":"14","author":"Okunade KS","year":"2016","unstructured":"Okunade KS, Okunola H, Okunowo AA, Anorlu RI. A five year review of ovarian cancer at a tertiary institution in Lagos, South-West, Nigeria. Niger J Gen Pract. 2016, 14:23-7. 10.4103\/1118-4647.187901","journal-title":"Niger J Gen Pract"},{"key":"ref3","article-title":"Cancer of the ovary","author":"Kosary CL","year":"2007","unstructured":"Kosary CL. Cancer of the ovary. SEER Survival Monograph: Cancer Survival Among Adults: U.S. SEER Program, 1988-2001, Patient and Tumor Characteristics. SEER Program. Ries LA, Young JL, Keel GE, Eisner MP, Lin YD, Horner MJ (ed): National Cancer Institute, Bethesda, MD; 2007. 133-44."},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1007\/s13277-016-5166-z","article-title":"A novel index for preoperative, non-invasive prediction of macro-radical primary surgery in patients with stage IIIC-IV ovarian cancer-a part of the Danish prospective pelvic mass study","volume":"37","author":"Karlsen MA","year":"2016","unstructured":"Karlsen MA, Fag\u00f6-Olsen C, H\u00f8gdall E, et al.. A novel index for preoperative, non-invasive prediction of macro-radical primary surgery in patients with stage IIIC-IV ovarian cancer-a part of the Danish prospective pelvic mass study. Tumour Biol. 2016, 37:12619-26. 10.1007\/s13277-016-5166-z","journal-title":"Tumour Biol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.11604\/pamj.2020.36.272.17827","article-title":"Risk predictors of early recurrence in women with epithelial ovarian cancer in Lagos, Nigeria","volume":"36","author":"Okunade KS","year":"2020","unstructured":"Okunade KS, Adetuyi IE, Adenekan M, Ohazurike E, Anorlu RI. Risk predictors of early recurrence in women with epithelial ovarian cancer in Lagos, Nigeria. Pan Afr Med J. 2020, 36:272. 10.11604\/pamj.2020.36.272.17827","journal-title":"Pan Afr Med J"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygyno.2013.05.040","article-title":"Survival impact of complete cytoreduction to no gross residual disease for advanced-stage ovarian cancer: a meta-analysis","volume":"130","author":"Chang SJ","year":"2013","unstructured":"Chang SJ, Hodeib M, Chang J, Bristow RE. Survival impact of complete cytoreduction to no gross residual disease for advanced-stage ovarian cancer: a meta-analysis. Gynecol Oncol. 2013, 130:493-8. 10.1016\/j.ygyno.2013.05.040","journal-title":"Gynecol Oncol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0908806","article-title":"Neoadjuvant chemotherapy or primary surgery in stage IIIC or IV ovarian cancer","volume":"363","author":"Vergote I","year":"2010","unstructured":"Vergote I, Trop\u00e9 CG, Amant F, et al.. Neoadjuvant chemotherapy or primary surgery in stage IIIC or IV ovarian cancer. N Engl J Med. 2010, 363:943-53. 10.1056\/NEJMoa0908806","journal-title":"N Engl J Med"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygyno.2015.11.022","article-title":"Prediction of incomplete primary debulking surgery in patients with advanced ovarian cancer: an external validation study of three models using computed tomography","volume":"140","author":"Rutten IJ","year":"2016","unstructured":"Rutten IJ, van de Laar R, Kruitwagen RF, et al.. Prediction of incomplete primary debulking surgery in patients with advanced ovarian cancer: an external validation study of three models using computed tomography. Gynecol Oncol. 2016, 140:22-8. 10.1016\/j.ygyno.2015.11.022","journal-title":"Gynecol Oncol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1002\/jso.21398","article-title":"Preoperative serum CA-125 levels and risk of suboptimal cytoreduction in ovarian cancer: a meta-analysis","volume":"101","author":"Kang S","year":"2010","unstructured":"Kang S, Kim TJ, Nam BH, Seo SS, Kim BG, Bae DS, Park SY. Preoperative serum CA-125 levels and risk of suboptimal cytoreduction in ovarian cancer: a meta-analysis. J Surg Oncol. 2010, 101:13-7. 10.1002\/jso.21398","journal-title":"J Surg Oncol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygyno.2005.07.123","article-title":"Ovarian cancer surgical resectability: relative impact of disease, patient status, and surgeon","volume":"100","author":"Aletti GD","year":"2006","unstructured":"Aletti GD, Gostout BS, Podratz KC, Cliby WA. Ovarian cancer surgical resectability: relative impact of disease, patient status, and surgeon. Gynecol Oncol. 2006, 100:33-7. 10.1016\/j.ygyno.2005.07.123","journal-title":"Gynecol Oncol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2014.56.3106","article-title":"Does aggressive surgery improve outcomes? Interaction between preoperative disease burden and complex surgery in patients with advanced-stage ovarian cancer: an analysis of GOG 182","volume":"33","author":"Horowitz NS","year":"2015","unstructured":"Horowitz NS, Miller A, Rungruang B, et al.. Does aggressive surgery improve outcomes? Interaction between preoperative disease burden and complex surgery in patients with advanced-stage ovarian cancer: an analysis of GOG 182. J Clin Oncol. 2015, 33:937-43. 10.1200\/JCO.2014.56.3106","journal-title":"J Clin Oncol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.tjog.2013.10.041","article-title":"Surgical outcome prediction in patients with advanced ovarian cancer using computed tomography scans and intraoperative findings","volume":"53","author":"Kim HJ","year":"2014","unstructured":"Kim HJ, Choi CH, Lee YY, Kim TJ, Lee JW, Bae DS, Kim BG. Surgical outcome prediction in patients with advanced ovarian cancer using computed tomography scans and intraoperative findings. Taiwan J Obstet Gynecol. 2014, 53:343-7. 10.1016\/j.tjog.2013.10.041","journal-title":"Taiwan J Obstet Gynecol"},{"key":"ref13","article-title":"Nomogram for suboptimal cytoreduction at primary surgery for advanced stage ovarian cancer","volume":"31","author":"Gerestein CG","year":"2011","unstructured":"Gerestein CG, Eijkemans MJ, Bakker J, Elgersma OE, van der Burg ME, Kooi GS, Burger CW. Nomogram for suboptimal cytoreduction at primary surgery for advanced stage ovarian cancer. Anticancer Res. 2011, 31:4043-9.","journal-title":"Anticancer Res"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2002.20.5.1248","article-title":"Survival effect of maximal cytoreductive surgery for advanced ovarian carcinoma during the platinum era: a meta-analysis","volume":"20","author":"Bristow RE","year":"2002","unstructured":"Bristow RE, Tomacruz RS, Armstrong DK, Trimble EL, Montz FJ. Survival effect of maximal cytoreductive surgery for advanced ovarian carcinoma during the platinum era: a meta-analysis. J Clin Oncol. 2002, 20:1248-59. 10.1200\/JCO.2002.20.5.1248","journal-title":"J Clin Oncol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1993.11.1.166","article-title":"Preoperative abdominopelvic computed tomographic prediction of optimal cytoreduction in epithelial ovarian carcinoma","volume":"11","author":"Nelson BE","year":"1993","unstructured":"Nelson BE, Rosenfield AT, Schwartz PE. Preoperative abdominopelvic computed tomographic prediction of optimal cytoreduction in epithelial ovarian carcinoma. J Clin Oncol. 1993, 11:166-72. 10.1200\/JCO.1993.11.1.166","journal-title":"J Clin Oncol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.2214\/ajr.165.4.7676985","article-title":"Ovarian carcinoma: value of CT in predicting success of debulking surgery","volume":"165","author":"Meyer JI","year":"1995","unstructured":"Meyer JI, Kennedy AW, Friedman R, Ayoub A, Zepp RC. Ovarian carcinoma: value of CT in predicting success of debulking surgery. AJR Am J Roentgenol. 1995, 165:875-8. 10.2214\/ajr.165.4.7676985","journal-title":"AJR Am J Roentgenol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygyno.2004.06.054","article-title":"Role of CT and MR imaging in predicting optimal cytoreduction of newly diagnosed primary epithelial ovarian cancer","volume":"96","author":"Qayyum A","year":"2005","unstructured":"Qayyum A, Coakley FV, Westphalen AC, Hricak H, Okuno WT, Powell B. Role of CT and MR imaging in predicting optimal cytoreduction of newly diagnosed primary epithelial ovarian cancer. Gynecol Oncol. 2005, 96:301-6. 10.1016\/j.ygyno.2004.06.054","journal-title":"Gynecol Oncol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejrad.2009.04.061","article-title":"The utility of multi-detector computed tomography in the diagnosis of malignant pleural effusion in the patients with ovarian cancer","volume":"75","author":"Kim KW","year":"2010","unstructured":"Kim KW, Choi HJ, Kang S, et al.. The utility of multi-detector computed tomography in the diagnosis of malignant pleural effusion in the patients with ovarian cancer. Eur J Radiol. 2010, 75:230-5. 10.1016\/j.ejrad.2009.04.061","journal-title":"Eur J Radiol"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijgo.2013.10.001","article-title":"Staging classification for cancer of the ovary, fallopian tube, and peritoneum","volume":"124","author":"Prat J","year":"2014","unstructured":"Prat J. Staging classification for cancer of the ovary, fallopian tube, and peritoneum. Int J Gynaecol Obstet. 2014, 124:1-5. 10.1016\/j.ijgo.2013.10.001","journal-title":"Int J Gynaecol Obstet"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1200\/GO.20.00450","article-title":"Predictors of survival outcomes after primary treatment of epithelial ovarian cancer in Lagos, Nigeria","volume":"7","author":"Okunade KS","year":"2021","unstructured":"Okunade KS, Adejimi AA, Ohazurike EO, et al.. Predictors of survival outcomes after primary treatment of epithelial ovarian cancer in Lagos, Nigeria. JCO Glob Oncol. 2021, 7:89-98. 10.1200\/GO.20.00450","journal-title":"JCO Glob Oncol"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygyno.2015.03.049","article-title":"Predictors of optimal cytoreduction in patients with newly diagnosed advanced-stage epithelial ovarian cancer: time to incorporate laparoscopic assessment into the standard of care","volume":"137","author":"G\u00f3mez-Hidalgo NR","year":"2015","unstructured":"G\u00f3mez-Hidalgo NR, Martinez-Cannon BA, Nick AM, Lu KH, Sood AK, Coleman RL, Ramirez PT. Predictors of optimal cytoreduction in patients with newly diagnosed advanced-stage epithelial ovarian cancer: time to incorporate laparoscopic assessment into the standard of care. Gynecol Oncol. 2015, 137:553-8. 10.1016\/j.ygyno.2015.03.049","journal-title":"Gynecol Oncol"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1006\/gyno.2000.5749","article-title":"The ability of preoperative serum CA-125 to predict optimal primary tumor cytoreduction in stage III epithelial ovarian carcinoma","volume":"77","author":"Chi DS","year":"2000","unstructured":"Chi DS, Venkatraman ES, Masson V, Hoskins WJ. The ability of preoperative serum CA-125 to predict optimal primary tumor cytoreduction in stage III epithelial ovarian carcinoma. Gynecol Oncol. 2000, 77:227-31. 10.1006\/gyno.2000.5749","journal-title":"Gynecol Oncol"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1111\/j.1525-1438.2007.00931.x","article-title":"Pattern and clinical predictors of lymph node metastases in epithelial ovarian cancer","volume":"17","author":"Harter P","year":"2007","unstructured":"Harter P, Gnauert K, Hils R, Lehmann TG, Fisseler-Eckhoff A, Traut A, du Bois A. Pattern and clinical predictors of lymph node metastases in epithelial ovarian cancer. Int J Gynecol Cancer. 2007, 17:1238-44. 10.1111\/j.1525-1438.2007.00931.x","journal-title":"Int J Gynecol Cancer"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1016\/S1072-7515(03)00234-5","article-title":"Lymph node involvement in epithelial ovarian cancer: analysis of 276 pelvic and paraaortic lymphadenectomies and surgical implications","volume":"197","author":"Morice P","year":"2003","unstructured":"Morice P, Joulie F, Camatte S, et al.. Lymph node involvement in epithelial ovarian cancer: analysis of 276 pelvic and paraaortic lymphadenectomies and surgical implications. J Am Coll Surg. 2003, 197:198-205. 10.1016\/S1072-7515(03)00234-5","journal-title":"J Am Coll Surg"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(20001001)89:7<1532::aid-cncr17>3.0.co;2-a","article-title":"A model for predicting surgical outcome in patients with advanced ovarian carcinoma using computed tomography","volume":"89","author":"Bristow RE","year":"2000","unstructured":"Bristow RE, Duska LR, Lambrou NC, Fishman EK, O'Neill MJ, Trimble EL, Montz FJ. A model for predicting surgical outcome in patients with advanced ovarian carcinoma using computed tomography. Cancer. 2000, 89:1532-40. 10.1002\/1097-0142(20001001)89:7&lt;1532::aid-cncr17&gt;3.0.co;2-a","journal-title":"Cancer"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygyno.2014.07.002","article-title":"A multicenter prospective trial evaluating the ability of preoperative computed tomography scan and serum CA-125 to predict suboptimal cytoreduction at primary debulking surgery for advanced ovarian, fallopian tube, and peritoneal cancer","volume":"134","author":"Suidan RS","year":"2014","unstructured":"Suidan RS, Ramirez PT, Sarasohn DM, et al.. A multicenter prospective trial evaluating the ability of preoperative computed tomography scan and serum CA-125 to predict suboptimal cytoreduction at primary debulking surgery for advanced ovarian, fallopian tube, and peritoneal cancer. Gynecol Oncol. 2014, 134:455-61. 10.1016\/j.ygyno.2014.07.002","journal-title":"Gynecol Oncol"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1245\/s10434-013-3224-y","article-title":"Efficacy of cytoreductive surgery with hyperthermic intraperitoneal chemotherapy in the management of malignant ascites","volume":"21","author":"Randle RW","year":"2014","unstructured":"Randle RW, Swett KR, Swords DS, Shen P, Stewart JH, Levine EA, Votanopoulos KI. Efficacy of cytoreductive surgery with hyperthermic intraperitoneal chemotherapy in the management of malignant ascites. Ann Surg Oncol. 2014, 21:1474-9. 10.1245\/s10434-013-3224-y","journal-title":"Ann Surg Oncol"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1007\/s00432-014-1692-5","article-title":"Different sequential approaches of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in treating ovarian cancer with malignant ascites","volume":"140","author":"Ba M","year":"2014","unstructured":"Ba M, Long H, Zhang X, et al.. Different sequential approaches of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in treating ovarian cancer with malignant ascites. J Cancer Res Clin Oncol. 2014, 140:1497-506. 10.1007\/s00432-014-1692-5","journal-title":"J Cancer Res Clin Oncol"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.22034\/APJCP.2018.19.5.1319","article-title":"Model for prediction of optimal debulking of epithelial ovarian cancer","volume":"19","author":"Arab M","year":"2018","unstructured":"Arab M, Jamdar F, Sadat Hosseini M, Ghodssi- Ghasemabadi R, Farzaneh F, Ashrafganjoei T. Model for prediction of optimal debulking of epithelial ovarian cancer. Asian Pac J Cancer Prev. 2018, 19:1319-24. 10.22034\/APJCP.2018.19.5.1319","journal-title":"Asian Pac J Cancer Prev"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygyno.2015.04.013","article-title":"Development of a prediction model for residual disease in newly diagnosed advanced ovarian cancer","volume":"138","author":"Janco JM","year":"2015","unstructured":"Janco JM, Glaser G, Kim B, et al.. Development of a prediction model for residual disease in newly diagnosed advanced ovarian cancer. Gynecol Oncol. 2015, 138:70-7. 10.1016\/j.ygyno.2015.04.013","journal-title":"Gynecol Oncol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/66867-preoperative-predictors-of-optimal-tumor-resectability-in-patients-with-epithelial-ovarian-cancer","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T14:35:58Z","timestamp":1707489358000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/66867-preoperative-predictors-of-optimal-tumor-resectability-in-patients-with-epithelial-ovarian-cancer"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,19]]},"references-count":30,"URL":"https:\/\/doi.org\/10.7759\/cureus.21409","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2022,1,19]]}}}